PM360 2021 Trailblazer Awards Patient/Consumer Education Silver Winner Alexion Pharmaceuticals and Snow Companies

aHUS Journey Patient Resource Kit (Alexion Pharmaceuticals, Snow Companies)

Atypical hemolytic uremic syndrome (aHUS) is a genetic, chronic, and life-threatening ultra-rare disease that can progressively damage vital organs, such as the kidneys.

Generally, patients receive their diagnosis and first treatment in emergency situations and are often overwhelmed, fearful, and uncertain about next steps.

Alexion Pharmaceuticals, in partnership with Snow Companies, designed the aHUS Journey Patient Resource Kit to help aHUS patients navigate this uncertainty with greater confidence. Alongside treatment brochures, the kit contains information on support programs, webinars, community engagements, and opportunities to get involved as a patient advocate.

In parallel with the physical kit, the team launched, a “digital kit” providing access to the same resources through an alternative channel.

Community feedback on the kit has been resoundingly positive. Fittingly, the kit’s PM360 Silver Award recognition was announced on the eve of the 7th Annual aHUS Awareness Day. The team hopes this recognition will help to further awareness for this ultra-rare community.


You May Also Like

My Other Life with Alejandro Arciniegas

PM360 recently spoke to Alejandro Arciniegas, Director, Remodulin Marketing at United Therapeutics Corporation, about ...

The Consequences of Pandemic-induced Healthcare Delays

The SARS-CoV-2 pandemic has led to many negative health outcomes besides those directly attributable ...

PM360 2018 Innovative Company Enable Injections

Enable Injections Jennifer King, Marketing Manager This year, Enable Injections transformed from an ...